INS and metabolic dysfunction-associated steatotic liver disease: Consequently, in patients suffering from NAFLD, genetic, extracellular, and intracellular factors disturb insulin signaling pathways, contributing to maintenance and worsening the inappropriate response of cells to insulin [50].